Navigation Links
Cambrex Reports Fourth Quarter and Full Year 2009 Results
Date:2/10/2010

485 70.3% ------- ------- Gross Profit 70,278 29.7% 73,743 29.5% Operating Expenses Selling, General and Administrative Expenses 35,711 15.0% 40,521 16.2% Research and Development Expenses 7,929 3.4% 7,590 3.0% Restructuring Expenses - 0.0% 4,695 1.9% Strategic Alternative Costs - 0.0% 1,515 0.6% ------- ------- Total Operating Expenses 43,640 18.4% 54,321 21.7% ------- ------- Operating Profit 26,638 11.3% 19,422 7.8% Other Expenses/(Income): Interest Expense, net 4,634 2.0% 3,668 1.5% Other (Income)/Expense, net (641) -0.3% 754 0.3% ------- ------- Income Before Income Taxes 22,645 9.6% 15,000 6.0% Provision for Income Taxes 12,253 5.2% 7,071 2.8% ------- ------- Net Income
'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
2. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex Reports Third Quarter 2008 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports First Quarter 2009 Results
7. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... April 18 Osteotech, Inc.,(Nasdaq: OSTE ), ... solutions for,regenerative medicine, announced today that it has ... Atlantic Transplant Alliance,("EATA"), a Bulgarian public non-profit foundation. ... for an initial term of seven years and,automatically ...
... 18 MED3OOO Group, Inc. (MED3OOO), a,national ... Inc. of Michigan City, IN, recently selected ... MED3OOO -- for billing, marketing, and business,support ... twenty-physician pathology practice,providing services to a large ...
... April 17 BrainCells Inc. (BCI), a,biopharmaceutical company ... that promote the growth of new neurons for ... today that it raised an,additional $20 million in ... total to $50 million. New investor, New Enterprise ...
Cached Biology Technology:Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 2Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance 3Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner 2Pathology Consultants, Inc. Selects PSA, LLC, a MED3OOO Company, as Their Business Partner 3BrainCells Inc. Expands Series B Financing to $50 Million 2
(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/21/2014)... Calif. , Nov. 20, 2014   Atmel® ... leader in microcontroller (MCU) and touch technology solutions, today ... temperature sensors with the widest V cc ... higher temperature accuracy and faster I 2 C bus ... and serial EEPROM memory making them ideal for consumer, ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... eye require vitamin C in order to function properly ... elsewhere in the brain for its proper functioning, according to ... recently published in the Journal of Neuroscience. "We found ... relatively high doses of vitamin C, inside and out, to ...
... of insect cocoons have allowed researchers in Argentina to ... webs devoted to consuming rotting dinosaur eggs. The research ... Palaeontology . The approximately 70 million year ... in 1989 in the Patagonia region of Argentina, well ...
... Medicine have found that grape seed polyphenolsa natural antioxidantmay ... Alzheimer,s disease. The research, led by Giulio Maria Pasinetti, ... Professor of Psychiatry and Geriatrics and Adult Development at ... the current issue of the Journal of Alzheimer,s ...
Cached Biology News:OHSU scientists discover new role for vitamin C in the eye -- and the brain 2Fossil forensics reveals how wasps populated rotting dinosaur eggs 2Natural chemical found in grapes may protect against Alzheimer's disease 2
... Versatile state of the Art GLP ... to dual 38,000 L fermentation. ... to production. Aseptic operation capable ... Fed-Batch, and Continuous Modes. Hosts ...
... 200 g of lyophilized peptide derived from ... acids 380-402; GLTPSAWEASSLRSSRHSGLSHF. This peptide ... of Cayman's EP1 receptor polyclonal antibody (Catalog ... conjunction with this antibody to block protein-antibody ...
Anti-ZFP200 Family: Zinc Finger Peptide Sequence: CGKSFNHKTNLNKHER...
Complete cell culture media with cytokines...
Biology Products: